Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-07
DOI
10.1038/s41380-021-01121-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
- (2021) Adriana Feder et al. AMERICAN JOURNAL OF PSYCHIATRY
- A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes
- (2021) Yaoyu Pu et al. BRAIN BEHAVIOR AND IMMUNITY
- Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients
- (2021) Xiaoyu Chen et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Neural rhythm in the retrosplenial cortex during ketamine-induced dissociation
- (2021) Kenji Hashimoto EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers
- (2021) Torsten Passie et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
- (2021) Plinio C. Casarotto et al. CELL
- Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine
- (2021) Steven F. Grieco et al. Translational Psychiatry
- Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling
- (2021) Yuko Fujita et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling
- (2021) Yan Wei et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
- (2020) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine
- (2020) Zhongwei Xiong et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A historical review of antidepressant effects of ketamine and its enantiomers
- (2020) Yan Wei et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
- (2020) Kai Zhang et al. Translational Psychiatry
- d-glutamate and Gut Microbiota in Alzheimer’s Disease
- (2020) Chun-Hung Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice
- (2020) Yunfei Tan et al. JOURNAL OF AFFECTIVE DISORDERS
- Brain control of humoral immune responses amenable to behavioural modulation
- (2020) Xu Zhang et al. NATURE
- (2R,6R)-Hydroxynorketamine (HNK) plasma level predicts poor antidepressant response: is this the end of the HNK pipeline?
- (2020) Chadi G. Abdallah NEUROPSYCHOPHARMACOLOGY
- Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
- (2020) Cristan A. Farmer et al. NEUROPSYCHOPHARMACOLOGY
- (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression
- (2020) Rei Yokoyama et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?
- (2020) Kenji Hashimoto PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The spleen mediates chronic sleep restriction-mediated enhancement of LPS-induced neuroinflammation, cognitive deficits, and anxiety-like behavior
- (2020) Dan Xu et al. Aging-US
- Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
- (2020) Kenji Hashimoto BIOCHEMICAL PHARMACOLOGY
- Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain–gut–microbiota axis
- (2020) Youge Qu et al. JOURNAL OF AFFECTIVE DISORDERS
- Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: A role of brain–spleen axis
- (2020) Jiancheng Zhang et al. JOURNAL OF AFFECTIVE DISORDERS
- Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
- (2020) Masaki Kato et al. MOLECULAR PSYCHIATRY
- Assessment of Ketamine and its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness
- (2020) Jackie Zhu et al. International Journal of Environmental Research and Public Health
- A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration
- (2020) Jiancheng Zhang et al. Translational Psychiatry
- Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders
- (2020) Liang Shi et al. Translational Psychiatry
- Association Between FoxO1, A2M, and TGF-β1, Environmental Factors, and Major Depressive Disorder
- (2020) Mingzhe Zhao et al. Frontiers in Psychiatry
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- Ingestion of Lactobacillus intestinalis and Lactobacillus reuteri causes depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve
- (2020) Siming Wang et al. Journal of Neuroinflammation
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression
- (2020) Paulo R. Shiroma et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant actions of ketamine engage cell-specific translation via eIF4E
- (2020) Argel Aguilar-Valles et al. NATURE
- The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
- (2020) Hartej Gill et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The role of dissociation in ketamine’s antidepressant effects
- (2020) Elizabeth D. Ballard et al. Nature Communications
- Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study
- (2020) Mu-Hong Chen et al. GENOMICS
- Ketamine: A Paradigm Shift for Depression Research and Treatment
- (2019) John H. Krystal et al. NEURON
- Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective
- (2019) Álvaro López-Díaz et al. BRITISH JOURNAL OF PSYCHIATRY
- The role of short-chain fatty acids in microbiota–gut–brain communication
- (2019) Boushra Dalile et al. Nature Reviews Gastroenterology & Hepatology
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
- (2019) Ronald S. Duman et al. NEURON
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Depression researchers rethink popular mouse swim tests
- (2019) Sara Reardon NATURE
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
- (2019) Lijia Chang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model
- (2019) Zhongwei Xiong et al. BEHAVIOURAL BRAIN RESEARCH
- The Microbiota-Gut-Brain Axis
- (2019) John F. Cryan et al. PHYSIOLOGICAL REVIEWS
- MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling
- (2019) Atsuhiro Fujita et al. PSYCHOPHARMACOLOGY
- Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress
- (2019) Kai Zhang et al. Translational Psychiatry
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine
- (2019) Kai Zhang et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress
- (2019) Siming Wang et al. JOURNAL OF AFFECTIVE DISORDERS
- The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
- (2019) David S. Mathai et al. JOURNAL OF AFFECTIVE DISORDERS
- Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine: Role of BDNF-TrkB signaling
- (2019) Yunfei Tan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Common Neurotransmission Recruited in ( R , S )-Ketamine and (2 R ,6 R )-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects
- (2018) Thu Ha Pham et al. BIOLOGICAL PSYCHIATRY
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- What Are the Causes for Discrepancies of Antidepressant Actions of (2 R ,6 R )-Hydroxynorketamine?
- (2018) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Is (S)-norketamine an alternative antidepressant for esketamine?
- (2018) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- NMDAR-independent, cAMP-dependent antidepressant actions of ketamine
- (2018) Nathan H. Wray et al. MOLECULAR PSYCHIATRY
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- Synthesis of Some Novel Thiadiazole Derivative Compounds and Screening Their Antidepressant-Like Activities
- (2018) Nafiz Can et al. MOLECULES
- (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
- (2018) Dylan Chou et al. NEUROPHARMACOLOGY
- (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
- (2018) Jun-ichi Yamaguchi et al. NEUROPSYCHOPHARMACOLOGY
- Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target
- (2018) Filippo Caraci et al. PHARMACOLOGICAL RESEARCH
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
- (2018) Kai Zhang et al. Scientific Reports
- Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression
- (2018) Yanling Zhou et al. BRAIN BEHAVIOR AND IMMUNITY
- Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
- (2018) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
- (2018) Yanling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
- (2018) Kai Zhang et al. PSYCHOPHARMACOLOGY
- Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
- (2018) Todd D. Gould et al. Annual Review of Pharmacology and Toxicology
- Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties
- (2018) Bruk Getachew et al. BMC MICROBIOLOGY
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression
- (2018) Alexandra D Frolkis et al. GUT
- Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression
- (2018) Niannian Huang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
- (2018) Kenichi Fukumoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
- (2017) Kai Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
- (2017) Yukihiko Shirayama et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders
- (2017) Samuel T. Wilkinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms
- (2017) I-Hua Wei et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
- (2017) B Kadriu et al. MOLECULAR PSYCHIATRY
- Targeting glutamate signalling in depression: progress and prospects
- (2017) James W. Murrough et al. NATURE REVIEWS DRUG DISCOVERY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model
- (2017) Youge Qu et al. Scientific Reports
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
- (2017) Chun Yang et al. Translational Psychiatry
- Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis
- (2017) B Yang et al. Translational Psychiatry
- Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice
- (2017) Chun Yang et al. Scientific Reports
- High-Coverage Whole-Exome Sequencing Identifies Candidate Genes for Suicide in Victims with Major Depressive Disorder
- (2017) Dóra Tombácz et al. Scientific Reports
- Detrimental Side Effects of Repeated Ketamine Infusions in the Brain
- (2016) Kenji Hashimoto AMERICAN JOURNAL OF PSYCHIATRY
- Post-Stroke Depression: A Review
- (2016) Robert G. Robinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
- (2016) Ji-chun Zhang et al. Current Neuropharmacology
- Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
- (2016) Yukihiko Shirayama et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine’s antidepressant action: beyond NMDA receptor inhibition
- (2016) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
- (2016) Bangkun Yang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy
- (2016) Gavin Rush et al. JOURNAL OF AFFECTIVE DISORDERS
- From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
- (2016) G B Rogers et al. MOLECULAR PSYCHIATRY
- Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
- (2016) M-L Wong et al. MOLECULAR PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Detecting depression in Parkinson disease
- (2016) Zahra Goodarzi et al. NEUROLOGY
- BDNF – a key transducer of antidepressant effects
- (2016) Carl Björkholm et al. NEUROPHARMACOLOGY
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
- (2016) Chun Yang et al. PSYCHIATRY RESEARCH
- Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity
- (2016) K. Hashimoto PSYCHOLOGICAL MEDICINE
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice
- (2016) Wei Yao et al. Scientific Reports
- Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study
- (2016) K Hashimoto et al. Translational Psychiatry
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders
- (2015) Y. Ohgi et al. CURRENT MOLECULAR MEDICINE
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression
- (2015) Wen-Xue Liu et al. PSYCHOPHARMACOLOGY
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Targeting of NMDA Receptors in the Treatment of Major Depression
- (2014) Yong-Hui Dang et al. CURRENT PHARMACEUTICAL DESIGN
- What is hydroxynorketamine and what can it bring to neurotherapeutics?
- (2014) Nagendra S Singh et al. Expert Review of Neurotherapeutics
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
- (2014) Kenji Hashimoto Clinical Psychopharmacology and Neuroscience
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)
- (2013) Georges Mion et al. CNS Neuroscience & Therapeutics
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
- (2013) E. Nosyreva et al. JOURNAL OF NEUROSCIENCE
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine
- (2012) Lisa M. Monteggia et al. BIOLOGICAL PSYCHIATRY
- The Neuroprotective Functions of Transforming Growth Factor Beta Proteins
- (2012) Arpád Dobolyi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future
- (2012) E. F. Domino et al. SCHIZOPHRENIA BULLETIN
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment
- (2011) R. Musil et al. JOURNAL OF AFFECTIVE DISORDERS
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Roles of glutamate signaling in preclinical and/or mechanistic models of depression
- (2011) Kenichi Tokita et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity
- (2010) Eero Castrén et al. Developmental Neurobiology
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Emerging role of glutamate in the pathophysiology of major depressive disorder
- (2009) Kenji Hashimoto BRAIN RESEARCH REVIEWS
- Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats
- (2009) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
- Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
- (2007) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More